1. Cellular uptake, distribution and metabolism of phosphorothioate, phosphodiester, and methylphosphonate oligonucleotides;Crooke,1993
2. Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides;Geary;Anti-Cancer Drug Des.,1997
3. Pharmacokinetic properties of phosphorothioates in animals-absorption, distribution, metabolism and elimination;Nicklin,1998
4. Characterization of fully 2′-modified oligoribonucleotide hetero- and homo-duplex hybridization and nuclease sensitivity;Cummins;Nucleic Acids Res.,1995
5. Pharmacokinetics and bioavailability of antisense oligonucleotides following oral and colorectal administrations in experimental animals;Agrawal,1998